Literature DB >> 18088374

Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus.

Inês M Araújo1, Joana M Gil, Bruno P Carreira, Paul Mohapel, Asa Petersen, Paulo S Pinheiro, Denis Soulet, Ben A Bahr, Patrik Brundin, Caetana M Carvalho.   

Abstract

Evidence for increased calpain activity has been described in the hippocampus of rodent models of temporal lobe epilepsy. However, it is not known whether calpains are involved in the cell death that accompanies seizures. In this work, we characterized calpain activation by examining the proteolysis of calpain substrates and in parallel we followed cell death in the hippocampus of epileptic rats. Male Wistar rats were injected with kainic acid (10 mg/kg) intraperitoneally and killed 24 h later, after development of grade 5 seizures. We observed a strong Fluoro-Jade labeling in the CA1 and CA3 areas of the hippocampus in the rats that received kainic acid, when compared with saline-treated rats. Immunohistochemistry and western blot analysis for the calpain-derived breakdown products of spectrin showed evidence of increased calpain activity in the same regions of the hippocampus where cell death is observed. No evidence was found for caspase activation, in the same conditions. Treatment with the calpain inhibitor MDL 28170 significantly prevented the neurodegeneration observed in CA1. Taken together, our data suggest that early calpain activation, but not caspase activation, is involved in neurotoxicity in the hippocampus after status epilepticus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18088374     DOI: 10.1111/j.1471-4159.2007.05181.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Authors:  Vinogran Naidoo; David A Karanian; Subramanian K Vadivel; Johnathan R Locklear; JodiAnne T Wood; Mahmoud Nasr; Pamela Marie P Quizon; Emily E Graves; Vidyanand Shukla; Alexandros Makriyannis; Ben A Bahr
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

2.  Overexpression of μ-calpain in the anterior temporal neocortex of patients with intractable epilepsy correlates with clinicopathological characteristics.

Authors:  Zhan-hui Feng; Junwei Hao; Lan Ye; Carlos Dayao; Ning Yan; Yong Yan; Lan Chu; Fu-dong Shi
Journal:  Seizure       Date:  2011-02-10       Impact factor: 3.184

3.  Calpain activation and neuronal death during early epileptogenesis.

Authors:  Philip M Lam; Marco I González
Journal:  Neurobiol Dis       Date:  2018-11-10       Impact factor: 5.996

4.  Deletion of Puma protects hippocampal neurons in a model of severe status epilepticus.

Authors:  T Engel; S Hatazaki; K Tanaka; J H M Prehn; D C Henshall
Journal:  Neuroscience       Date:  2010-04-01       Impact factor: 3.590

5.  Calpains and delayed calcium deregulation in excitotoxicity.

Authors:  Inês M Araújo; Bruno P Carreira; Caetana M Carvalho; Arsélio P Carvalho
Journal:  Neurochem Res       Date:  2010-11-26       Impact factor: 3.996

6.  Cleavage of the vesicular GABA transporter under excitotoxic conditions is followed by accumulation of the truncated transporter in nonsynaptic sites.

Authors:  João R Gomes; Andrea C Lobo; Carlos V Melo; Ana R Inácio; Jiro Takano; Nobuhisa Iwata; Takaomi C Saido; Luís P de Almeida; Tadeusz Wieloch; Carlos B Duarte
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

7.  A calpain inhibitor ameliorates seizure burden in an experimental model of temporal lobe epilepsy.

Authors:  Philip M Lam; Jessica Carlsen; Marco I González
Journal:  Neurobiol Dis       Date:  2017-02-22       Impact factor: 5.996

8.  Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors.

Authors:  A Das; G C Wallace; C Holmes; M L McDowell; J A Smith; J D Marshall; L Bonilha; J C Edwards; S S Glazier; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2012-06-12       Impact factor: 3.590

Review 9.  Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases.

Authors:  Heena Khan; Nikhil Garg; Thakur Gurjeet Singh; Amarjot Kaur; Komal Thapa
Journal:  Neurochem Res       Date:  2022-01-04       Impact factor: 3.996

10.  Calpain-dependent cleavage of GABAergic proteins during epileptogenesis.

Authors:  Marco I González
Journal:  Epilepsy Res       Date:  2019-09-17       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.